TQH2722

TQH2722 · Chia Tai Tianqing Pharmaceutical Group

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TQH2722, covering 2023-08-01 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis [Phase 2]